Release Date: 04/11/11 17:02 Summary: Daily share buy-back notice - Appendix 3E Price Sensitive: No Download Document 88.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%